Western Midstream: 9.3% Yield With Room To Grow

Western Midstream agreed to acquire Aris Water Solutions for $1.5 billion to expand its water-treatment footprint in the Delaware Basin, with management guiding Aris will add $45–$50 million of adjusted EBITDA over 2.5 months (analyst assumption: ~$30 million incremental FCF per full quarter). The deal plus organic projects (Pathfinder pipeline in service Q1 2027 and North Loving II boosting processing >10%) should lift distribution coverage from ~1.12 to ~1.14 (1.16 including synergies) while the company carries $177 million cash against $6.9 billion debt (<3x net leverage). The partnership yields 9.3% today and the author’s valuation implies fair value of $45.5/unit (rising to $47.5 if distributions are increased to $0.95), though downside risks include prolonged low commodity prices and a ~40% Occidental stake controlling the GP.

Analysis

Market structure: The Aris acquisition makes WES (WES) a clearer winner — it increases fee-based water EBITDA and raises distribution coverage (author cites 1.12→1.14–1.16). Winners include water-focused midstream operators and service contractors; losers are small oilfield disposal players and equity holders in companies that lack scale to price water services. This shifts pricing power toward integrated players in the Delaware Basin where produced water intensity (~4.5–5.5 bbl water per bbl oil) keeps structural demand elevated even if oil/gas spot prices wobble.

Risk assessment: Tail risks include an unexpected large OXY (OXY) sell-down (>5–10% of float) depressing the unit price, EPA/state regulation that materially raises disposal costs, or operational failure/delay in Pathfinder or Aris integration (Pathfinder in service target Q1 2027). Near-term (days–weeks) risk: opportunistic OXY selling; short-term (months) risk: integration execution, quarterly EBITDA misses; long-term (years) risk: sustained low commodity prices cutting E&P volumes. Hidden dependency: Aris synergy capture depends on timely Pathfinder flow; failure there compresses coverage.

Trade implications: Establish a measured long in WES (2–4% portfolio) targeting $47.5/unit in 12–18 months assuming yield reversion to ~8% and a modest DPS bump; use a 20% stop or coverage<1.00 trigger. Hedge shareholder-concentration risk with a pair trade: long WES vs short OXY (dollar-neutral, start 1:0.6) to offset dilution risk. Use options to convexify: buy a 12–18 month WES protective put spread (buy 2026 Jan 40P / sell 2026 Jan 30P) sized to 25–50% of the equity position; consider selling covered calls after a >10% advance.

Contrarian angles: Consensus underestimates execution risk and OXY-driven liquidity events; it may also underprice regulatory risk to produced-water economics. Conversely the market likely underreacts to durable fee-based cashflow value — if management grows coverage to >1.20 or announces distribution increase >5% next year, upside could materialize quickly (15–25%). Historical parallel: MLPs acquired/expanded into adjacent services often trade up after proof-of-integration; failure modes are integration delays and anchor-shareholder sell-downs which would create short-term dislocations to exploit.

Key Decisions for Investors

• Establish a 2–4% long position in WES (units) within 30 days, target price $47.5 over 12–18 months (assumes yield compresses to ~8% and distribution raised to ~$0.95), set tactical stop-loss at -20% or if distribution coverage falls below 1.00 on reported quarterly results.
• Enter a dollar‑neutral pair: long WES vs short OXY sized 1:0.6 (start size 1–2% portfolio exposure net) to hedge risk of Occidental selling common units; reassess after any OXY 10-Q/10-K or block sale within 30–60 days.
• Buy a 12–18 month protective put spread on WES to hedge downside: buy Jan 2026 40P and sell Jan 2026 30P sized to cover 25–50% of the long position; this caps downside while keeping carry costs low.
• Avoid increasing exposure to other high-leverage water/disposal pure-plays until Aris integration proof points (first 2 quarterly reports). Rotate modestly from broad MLP peers (e.g., EPD, ET) into WES if Q3–Q4 EBITDA shows Aris contribution ≥$45–50m over 2.5 months and synergy guidance is confirmed.
• Reduce WES exposure if Henry Hub < $2.50 for two consecutive quarters or if management delays Pathfinder beyond H1 2027; monitor regulatory notices on produced-water rules and OXY share activity in the next 30–90 days as explicit sell/triggers.